Advancing bioresorbable scaffolds through innovative biomaterials

With an unrestricted educational grant from REVA MEDICAL

Chairperson: A. Abizaid

Learning Objectives

  • To gain insight into REVA's novel biomaterials specifically developed for interventional product performance
  • To see current clinical data from the ReZolve2 bioresorbable scaffold
  • To learn about REVA's product pipeline, including preclinical testing and clinical trial plans for future bioresorbable scaffold products

Presentations available when logged in:

  • Introduction and objectives
  • Biomaterials designed for use in interventional cardiology
  • RESTORE II trial: clinical results from the ReZolve2 sirolimus-eluting bioresorbable scaffold
  • REVA's bioresorbable pipeline
  • Take-home message